US Markets

Health Care Sector Update for 07/27/2020: TCRR, MNOV, MRNA, XLV, IBB

Health care firms were rallying premarket Monday. The Health Care SPDR (XLV) was up 0.22% and the iShares NASDAQ Biotechnology Index (IBB) was 0.78% higher in recent pre-bell activity.

TCR2 Therapeutics (TCRR) was surging past 48% after it released positive interim data from its phase 1/2 study of TC-210, a drug candidate intended for the treatment of mesothelin-expressing solid tumors.

MediciNova (MNOV) was gaining over 13% in value as it obtained exclusive worldwide rights to develop BC-PIV, a human parainfluenza virus type 2 vector, into a potential vaccine against SARS-CoV-2, the virus that causes COVID-19.

Moderna (MRNA) was up more than 8% after saying it has started dosing the first patients in the phase 3 clinical trial of its mRNA vaccine candidate, mRNA-1273, against COVID-19. Earlier, the company said it will receive an additional commitment of up to $472 million from its contract with the Biomedical Advanced Research Development Authority (BARDA) for the development of its COVID-19 program.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

TCRR MNOV MRNA XLV IBB

Latest Markets Videos

MTNewswires

Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

Learn More